LFCR Shareholders Have Opportunity to Lead Lifecore Biomedical, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!Accesswire • 09/25/24
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)GlobeNewsWire • 09/24/24
The Schall Law Firm Urges Investor Participation In A Securities Fraud Case Against Lifecore Biomedical IncAccesswire • 09/24/24
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!Accesswire • 09/24/24
LFCR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCRGlobeNewsWire • 09/23/24
Lifecore Biomedical, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 27, 2024 Deadline to file Lead Plaintiff MotionGlobeNewsWire • 09/23/24
Lifecore Biomedical, Inc. Is Being Sued For Possible Securities Law Violations And Shareholders Are Invited To Contact The Schall Law FirmAccesswire • 09/23/24
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifecorePRNewsWire • 09/23/24
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 09/23/24
LFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud LawsuitPRNewsWire • 09/22/24
LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 09/22/24
Lifecore Biomedical, Inc. Is Being Sued For Securities Related Infractions And Impacted Stockholders Are Invited To Contact The Schall Law FirmAccesswire • 09/21/24
LFCR DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCRGlobeNewsWire • 09/20/24
The Schall Law Firm Encourages Investors To Take Part In A Case Against Lifecore Biomedical Inc For Securities FraudAccesswire • 09/20/24
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!Accesswire • 09/20/24
Lifecore Biomedical, Inc. Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Help The Schall Law FirmAccesswire • 09/19/24
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifecoreGlobeNewsWire • 09/19/24
LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!Accesswire • 09/19/24
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and OperationalGlobeNewsWire • 09/19/24
The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against Lifecore Biomedical IncAccesswire • 09/18/24
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 09/18/24
Faruqi & Faruqi Reminds Lifecore Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 27, 2024 - LFCRPRNewsWire • 09/17/24
Lifecore Biomedical, Inc. Is Being Sued For Violating Securities Laws And Impacted Shareholders Should Lend A Hand To The Schall Law FirmAccesswire • 09/17/24
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 09/17/24
LFCR DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCRGlobeNewsWire • 09/17/24
